ResMed issued FY2027 revenue guidance of $5.75B-$5.85B plus $1.85B+ shareholder returns.
Why it matters
ResMed issued FY2027 revenue guidance of $5.75B-$5.85B plus $1.85B+ shareholder returns. — impact context not separately stored; see What changed.